Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.

Cancer chemotherapy and pharmacology - 1 Jul 2009

Kim Jong Gwang, Sohn Sang Kyun, Chae Yee Soo, Song Hong Suk, Kwon Ki-Young, Do Young Rok, Kim Min Kyoung, Lee Kyung Hee, Hyun Myung Soo, Lee Won Sik, Sohn Chang-Hak, Jung Joo Seop, Kim Gab Chul, Chung Ho Young, Yu Wansik

Abstract excerpt

PURPOSE: The present study analyzed the polymorphisms of apoptosis-related genes and their impact on the response to chemotherapy and survival of patients with advanced gastric cancer. PATIENTS AND METHODS: Fifty-seven patients with advanced gastric cancer treated with paclitaxel and cisplatin combination chemotherapy were enrolled in the present study. The genomic DNA was extracted from paraffin-embedded tissue,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cisplatin

Share to Lymphatic Metastasis

Share to Neoplasm Staging

Share to Paclitaxel

Share to Stomach Neoplasms

Share to Survival Rate

Source

Identifiers

PMID: 19052714
DOI: 10.1007/s00280-008-0879-3

Genes

BID
LTA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.PMID 19052714Read ↗

TP53 Codon 72 Polymorphism Predicts Efficacy of Paclitaxel Plus Capecitabine Chemotherapy in Advanced Gastric Cancer Patients.Semantic proximity Read ↗

A p53 genetic polymorphism of gastric cancer: difference between early gastric cancer and advanced gastric cancer.Semantic proximity Read ↗

p53 Codon 72 polymorphism predicts the pathologic response to neoadjuvant chemotherapy in patients with breast cancer.Semantic proximity Read ↗

p53 codon 72 polymorphism in patients with gastric and colorectal cancer in a Korean population.Semantic proximity Read ↗

Meta-analysis of the association between P53 codon 72 polymorphisms and gastric cancer.Semantic proximity Read ↗

An updated meta-analysis of the p53 codon 72 polymorphism and gastric cancer risk.Semantic proximity Read ↗

TP53 codon 72 and intron 3 polymorphisms and mutational status in gastric cancer: an association with tumor onset and prognosis.Semantic proximity Read ↗

P53 codon 72 polymorphism and gastric cancer: A meta‐analysis of the literatureSemantic proximity Read ↗

Effect of TP53 codon 72 and MDM2 SNP309 polymorphisms on survival of gastric cancer among patients who receiving 5-fluorouracil-based postoperative adjuvant chemotherapy.Semantic proximity Read ↗

p53 Codon 72 Polymorphism and Gastric Cancer Risk in a Chinese Han PopulationSemantic proximity Read ↗

Prognostic value of TP53 codon 72 polymorphism in advanced gastric adenocarcinoma.Semantic proximity Read ↗

TP53 codon 72 polymorphism and breast cancer in northern Iran.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.